Sumitomo Dainippon to Reinstate Hara as Drug Development Head

Sumitomo Dainippon Pharma said on December 1 that Nobuyuki Hara will be reinstated as executive director of drug development in January in what seems to be a U-turn from his demotion earlier this year after lurasidone development in Japan hit...read more